Abstract The purpose of this study was to investigate and report prevalence and risk factors for persistent pain in breast cancer patients at 15 months and 7-9 years post surgery. A nationwide inception cohort study including 3343 women treated for primary breast cancer between 2001 and 2004, who returned a questionnaire 3 months post surgery. Socio-demographic and clinical information was obtained from registries. Questionnaire data on pain and health behaviors were obtained 15 months and 7-9 years post surgery. A total of 1905 women were eligible for analysis. At 15-month post surgery, 32.7 % reported pain ''almost every day'' or more frequently. At 7-9 years post surgery, the prevalence decreased to 20.4 %. Socio-demographic (young age, lower education, lower income, lower occupational status), treatment-related (being lymph node positive, axillary lymph node dissection (ALND), post-menopausal endocrine treatment), and health behavioral factors (smoking C 10 cigarettes/day, obesity (BMI C 30 and \ 35), comorbidity, poor physical function) were significantly associated with pain at 15 months. Being physically active and moderate alcohol intake (\3 units/day) were negatively associated with pain. At 7-9 years post surgery, only ALND (OR:1.41, p = 0.03), post-menopausal endocrine treatment (OR:1.62, p = 0.01), poorer physical function (ORs:2.00-2.40, p = 0.003), and weight training (h/week) at 15 months (OR:1.10, p = 0.008) were significant predictors of pain when adjusting for age and pain 15 months post surgery. No socio-demographic predictors remained statistically significant. Younger age, lower socio-economic status, more invasive surgery, endocrine treatment, and adverse health behaviors emerged as risk factors for persistent pain. The influence of risk factors changed over time, suggesting a complex course of pain development and maintenance.
Introduction
Persistent pain, lasting [3 months after surgery [1, 2] , is a frequent complication after breast cancer treatment, with larger studies reporting prevalences between 29 and 42 % [3] [4] [5] . Type of surgery has been associated with the development of pain with some studies [6, 7] , but not all [1, 3] , showing women who have received more invasive surgery (i.e., mastectomy) to report more pain than women who have received lumpectomy. Furthermore, women treated with axillary lymph node dissection (ALND) tend to report more pain compared to sentinel lymph node biopsy (SLNB) [1, 8, 9] . Another clinical risk factor is radiotherapy [1, 10, 11] . Although socio-demographic factors are less well studied, younger age has consistently been found to be associated with higher incidence of pain [1, 4, 6, 9, 12] .
Generally, the existing research is characterized by retrospective assessments, modest sample sizes, and considerable between-study variability in the operationalization of pain and the timing of assessment [1] . An exception is a large Danish study showing that 24.5 % of patients reported moderate-severe pain 1.5-3.5 years after surgery [3] and that increased risk of pain was associated with receiving radiotherapy, ALND, and younger age. Recently, follow-up data on the same cohort showed that 16 % of the women experienced moderate to severe pain at least weekly, 5 years after surgery [12] . While this study adds valuable information to our knowledge about the course of pain after breast cancer treatment, with the exception of age, the role of socio-demographic and health behavioral factors were not explored. Another relevant socio-demographic risk factor could be lower educational level which has been found associated with failure to return to work, higher sickness absence, and greater pain severity [13] [14] [15] [16] . There are also indications that certain health behaviors may negatively influence long-term pain development. Smoking, for example, has been found associated with greater pain severity and higher levels of pain interference [17] [18] [19] [20] . Physical activity and obesity have likewise been associated with the course of pain, with physical activity being inversely associated with pain and obesity predictive of higher pain levels [16, 20, 21] .
To the best of our knowledge, no studies so far have prospectively investigated long-term pain after breast cancer treatment and included treatment-related, socio-demographic, as well as health behavioral risk factors. As pain has been associated with impaired Quality of Life [22, 23] , psychological morbidity [24, 25] , and appears to persist in a substantial number of women after treatment, identification of patients at higher risk for developing persistent pain may offer valuable clinical information for the purpose of rehabilitation. We therefore investigated socio-demographic, treatment-related, and health behavioral predictors of persistent pain from 15 months to 7-9 years after breast cancer treatment in a large national cohort of women.
Methods

Study design and sample
The Psychosocial Factors and Breast Cancer Cohort is a nationwide inception cohort study of 4917 consecutively included Danish women treated for invasive breast cancer between 2001 and 2004 conducted in collaboration with the Danish Breast Cancer Cooperative Group (DBCG). Details of the cohort and recruitment procedure have been described elsewhere [26] . In brief, patient eligibility criteria at time of entry were as follows: 18-70 years of age, histologically confirmed invasive breast cancer T1-3, N0-3, and M0 according to the TNM classification [27] , and no history of other cancers, with the exception of non-melanoma skin cancer and carcinoma in situ of the cervix uteri. Further inclusion criteria included sufficient Danish language skills, ability to complete a questionnaire, and treatment according to DBCG standard guidelines. Eligible women were identified by the DBCG and the surgical departments and informed about the study. At least 97 % of all eligible women in Denmark during the inclusion period were identified [28] . Questionnaire packages were mailed out 3 months post surgery and returned by 3343 women (68 %) who thus constituted the original questionnaire cohort.
Eligibility in the present study
Additional data were collected 15 months and 7-9 years post surgery in 2011. At 15 months, 3136 of the responders at 3 months were alive and had no recurrence or secondary cancer according to the DBCG and the Danish Cancer Registry. Of these, 2932 (94 %) returned the questionnaire. At 7-9 years, 2289 women from the questionnaire cohort were still alive without signs of recurrence or new cancer, whereof 2070 (90.4 %) returned the questionnaire. Eighty women who reported a recurrence or malign secondary cancer were excluded together with 85 women, who did not have complete data on pain measures at both assessments. A total 1905 women were eligible and available for analysis in the present study (Fig. 1) . The study was approved by the Regional Science Ethical Committees and the Danish Data Protection Agency.
Adjuvant treatment
The DBCG standard protocols 2001A-E and 2004C for adjuvant therapy were effective during the study period [29] . For pre-menopausal women, the available protocols were A: No adjuvant therapy, B: 7 cycles of cyclophosphamide, epirubicin, and fluorouracil (CEF) followed by Tamoxifen for 5 years, and D: 7 cycles of CEF. Postmenopausal women were treated according to protocols: A, C: 2.5 years of treatment with Tamoxifen, followed by 2.5 years of Exemestane, and E: 7 cycles of cyclophosphamide, methotrexate, and fluorouracil (CMF). Exemestane was introduced in protocol C (2004C) from June 2004. Some women in this protocol had therefore been treated with Tamoxifen for up to 3.5 years before initiation of Exemestane treatment (2.5 years). Women who had received lumpectomy and women with positive lymph node(s) were allocated to radiotherapy (a total dose of 48 Gy in 24 fractions). Lumpectomized women received radiotherapy on the residual breast tissue, whereas women with positive lymph node(s) received locoregional radiotherapy. Women \50 years of age had received additional boost treatment against the tumor bed with 10-16 Gy in 5-8 fractions. Mastectomized node-positive women received anterior thoracic radiotherapy (48 Gy in 24 fractions) [29] .
Measures
Socio-demographic variables
Pre-cancer data concerning demographic factors, ethnicity, and socio-economic variables were obtained from the Danish longitudinal registries through a linkage serviced by Statistics Denmark [30] and included marital status, education, personal income, occupational status, and household net-wealth. Danish ethnicity was defined as Danish citizenship, being born in Denmark, and at least one parent a Danish citizen.
Clinical variables
Data on tumor characteristics and treatment were obtained through a linkage with the DBCG. The DBCG registry contains information on diagnosis, treatment, and followup reported by all departments in Denmark involved in the treatment of breast cancer, including tumor-related variables (tumor size, estrogen receptor status, nodal status involvement) and treatment (DBCG treatment protocols, surgical procedures, chemo-, radiation-, and endocrine therapy) [29] . Information on subsequent recurrence and secondary cancers was obtained through DBCG and the Danish Cancer Registries.
Comorbidity
Comorbidity was assessed at the surgical department at the time of primary surgery with the Charlson Comorbidity Index (CCI), measuring 19 comorbid conditions shown to alter the risk of mortality in longitudinal studies [31, 32] .
BMI and health behaviors at 15-month post surgery
Body mass index (BMI) was calculated and categorized according to WHO guidelines [33] . Smoking status and alcohol intake were self-reported total consumption during the last week in units per day (e.g., number of cigarettes, beers, glasses of wine). Physical activity was assessed with the Physical Activity Scale for the Elderly (PASE) [34] and included the total number of hours spent on walking, light-, moderate-, and strenuous activities, and weight training during the previous week. To reduce patient burden, PASE was modified to exclude basic household activities. Physical workload was defined as total hours/day spent on nonsedentary work involving some or more arm movements.
Physical function (PF) at 15-month post surgery
Physical function was assessed with the SF-36-PF subscale [35] measuring limitations in daily physical activities. Higher scores reflect higher levels of functioning (range 0-100).
Pain medication
Use of pain medication was as assessed by self-report at 7-9 years post surgery (yes/no response format). If yes, they were asked to indicate the number of days per week they had used pain medication.
Pain
Pain was assessed at 15 months and 7-9 years post surgery. The women were asked how often they had experienced pain during the last month at two body locations (the arm/shoulder of the operated side and the surgical area) with the response categories ''no pain''(0), ''a few times a month'' (1), ''a few times a week'' (2), ''almost every day'' (3), ''several times every day'' (4), and ''all the time'' (5). The women were also asked to rate the degree of pain burden with response options including ''minimally''(0), ''a little'' (1), ''some'' (2), ''much'' (3), and ''very much'' (4). A combined pain frequency variable was constructed by selecting the highest pain score reported in either the operated side or the surgical area. Pain frequency was categorized as ''high'' and ''low'' pain frequency using a cut-off C3 (high pain frequency = ''almost every day'' or more frequently; low pain frequency = ''no pain'', ''monthly pain'' or ''few days each week'').
Statistical analysis
The data were analyzed with binary logistic regression, with pain frequency (high = '1'; low = '0') as the dependent variable. A strong correlation was found at 7-9 years between pain frequency and pain burden (rho = 0.94; p \ 0.001), indicating that participants did not distinguish between these aspects of their pain experience. To avoid redundancy, only results for pain frequency are reported. In our main analyses, we explored predictors of change in pain frequency from 15 months to 7-9 years presented as odds ratios (OR) adjusted for baseline pain (15 months) and age (both included as continuous variables), as both pain frequency and several potential predictors varied with age. In addition, results for socio-demographic, clinical, and health behavioral variables were presented separately for 15 months and 7-9 years as OR's (both unadjusted and age-adjusted analyses). The statistical analyses of systemic therapies were stratified according to menopausal status in order to eliminate possible confounding effects of age. Predictors were considered statistically significant (p \ 0.05) if confirmed by the Wald statistic. Analyses were conducted with SPSS 19.0.0.1 (IBM SPSS Inc., Chicago, USA).
Results
At 15 months, 3136 women were identified as eligible, with 2923 (93.2 %) having completed the pain measure. Of these, a total of 2129 (72.8 %) reported pain during the last month (no further data shown). Of 2289 eligible women approached at 7-9 years follow-up with no signs of recurrence or new cancer, a total of 1905 women (83.2 %) had completed the pain assessments at both 15 months and 7-9 years post surgery and were thus available for analysis. For this sample (n = 1905), the median age at 15 months post surgery was 56.5 years (range: 27.3-71.2). Mean time from surgery was 15.2 months (SD:0.8) and 7.1 years (SD:0.7) at the first and second pain assessments, respectively. Analyses of women who dropped out from 15 months to 7-9 years post surgery (n = 167) revealed no differences in pain frequency (p = 0.10) or age (p = 0.85) at 15 months between completers and dropouts.
Pain prevalence
Of the 1905 women who completed questionnaires at both time points, a total of 1384 women (72.7 %) reported monthly or more frequent pain 15 months post surgery. At 7-9 years post surgery, 1100 women (57.7 %) reported pain at least monthly (Table 1) . Pain in the surgical area and pain in the arm/shoulder on the operated side were highly correlated (r = 0.61; p \ 0.001). However, pain was slightly more frequently reported in the arm/shoulder region of the side operated than in the surgical area at both time points (60.6 vs. 59.1 % at 15 months; 49.2 vs. 43.4 % at 7-9 years). The prevalence of high pain frequency decreased from 32.7 % at 15 months to 20.4 % at 7-9 years post surgery. In all, 10.3 % women changed status from low pain frequency at 15 months to high pain frequency at 7-9 years, while 58.9 % reporting high pain frequency at 15 months reported pain corresponding only to low pain frequency at 7-9 years post surgery.
Use of pain medication at 7-9 years post surgery A total of 1881 women completed the items concerning use of pain medication. Of these, a total of 658 women (35.0 %) reported having used pain medication during the previous month. More women in the high pain frequency group (216; 56.4 %) reported using pain medication during the previous month than in the low frequency pain group (442; 29.5 %) (p \ 0.001). The Inter Quartile Range (IQR, the 25-75 % percentile) for weekly use of pain medication was 0-4 days per week in the high pain frequency group and 0-1 days per week in the low pain frequency group.
Predictors of high pain frequency 15 months post surgery
As seen in Table 2 , younger age was associated with a higher pain frequency. Adjusting for age, higher pain frequency was associated with lower education, lower occupational status, lower personal income, and negative net-wealth. Adjusted for age, ALND, axillary node positive status, and endocrine treatment for post-menopausal women were significantly associated with pain (Table 3 ). Smoking C 10 cigarettes/day, obesity (BMI:30-34), poorer physical function, and comorbidity were also associated with high pain frequency at 15 months in the age-adjusted analyses. Factors associated with lower pain frequency were moderate alcohol consumption ([0 and\3 units of alcohol/day), moderate exercise, strenuous activities, and performing non-sedentary work (Table 4) .
Predictors of high pain frequency 7-9 years after surgery
Except from physical function, all health behavioral predictors measured at 15 months post surgery ceased to be significantly associated with pain 7-9 years post surgery, whereas socio-demographic and clinical risk factors associated with pain at 15 months were significantly predictive of pain at 7-9 years (unadjusted).
Predictors of change in pain frequency from 15 to 7-9 years after surgery
When investigating possible predictors of change in pain frequency from 15 months to 7-9 years post surgery by adjusting for age and pain at 15 months, no socio-demographic predictors reached statistical significance ( Table 2) . Of the treatment-related variables, ALND (vs. SNLB) and endocrine treatment (vs. no endocrine treatment) in postmenopausal women both showed to be statistically significant predictors of more frequent pain from 15 months to 7-9 years post surgery (Table 3) . Smoking, BMI, alcohol consumption, and physical workload did not reach statistical significance (Table 4) , while poorer physical function proved to be a significant predictor of more frequent pain over time when compared to women with better physical function. Physical activity was related to pain in the opposite direction than the associations observed at 15 months with walking and weight training being statistically significant associated with increased risk of pain from 15 months to 7-9 years post surgery. In order to identify possible independent predictors among types of physical activity (PASE), we conducted a multivariate regression analysis including all the PASE components while adjusting for age and pain at 15 months. In this model, weight training (h/week) emerged as the only independent statistically significant predictor (OR = 1.09; CI 1.01-1.19) (no further data shown). A result in the opposite direction was also found for comorbidity, with comorbidity predicting lower pain frequency from 15 months to 7-9 years post surgery.
Discussion
In this large nationwide follow-up study, one out of every five women treated for breast cancer reported pain almost every day or more frequently 7-9 years after surgery. Our results suggest that socio-demographic, treatment-related, and health behavioral factors influence the risk of At the time of data collection, protocols prescribed endocrine treatment as follows: pre-menopausal women were treated with Tamoxifen for 5yrs (protocol B), post-menopausal women were treated with Tamoxifen for 2.5 years (at minimum), followed by 2.5 years with AI treatment (protocol C) Table 4 Health behavioral predictors of high pain frequency at 15 months and 7-9 years after surgery in a national cohort of women treated for breast cancer developing pain in different ways over time, suggesting a complex course of persistent pain after breast cancer treatment. At 15-month post surgery, younger patients with lower socio-economic status (SES), i.e., lower education, income, and net wealth, were more likely to report pain. This is supported by previous reports with respect to young age [1, 4, 6, 9, 12] and, although less well studied, low education [4, 36] and low income [22, 36] . At 7-9 years post surgery, however, none of the socio-demographic variables remained statistically significant when adjusting for pain 15 months post surgery, suggesting that socio-demographic risk factors add no predictive value over time.
As previously observed [1, 8, 9] , ALND proved a strong treatment-related predictor of pain. Our results show that this risk persists even 7-9 years after surgery. Although associations between pain and type of surgery [6, 7] and radiotherapy [1, 3, 4, 6, 10] have previously been reported, we could not replicate these results. With respect to radiotherapy, it is possible that the influence on pain may already have declined when assessed at 15 months. However, other studies reporting radiotherapy as a predictor of persistent pain have used similar assessment points exceeding 13 months (e.g., [3, 4] ). Our results also revealed that post-menopausal women receiving endocrine treatment were at higher risk of pain at 15 months, a risk which persisted at 7-9 years post surgery. This could partially be explained by the addition of AIs after 2.5 years initial treatment with Tamoxifen in post-menopausal women, as AIs have indicated a stronger association with pain compared to Tamoxifen [37] [38] [39] .
We also found health behavioral variables to be associated with risk of persistent pain, particularly in the shorter term. Moderate alcohol consumption was thus associated with less pain at 15 months, whereas smoking [10 cigarettes per day and being obese (BMI C 30) was associated with more pain, but only at 15 months post surgery. That smoking is associated with increased pain is in general concordance with existing research [17] [18] [19] , while the results are mixed with respect to obesity [9, 14, 20, 21] . Our results suggest an adverse effect of obesity on pain, which, however, does not appear to persist over time. Furthermore, the relationship between pain and obesity appeared to be non-linear, with only obesity, and not severe obesity, reaching statistical significance. However, due to the small number of severely obese, this could be a statistical power issue. Poorer physical function was strongly associated with pain at both 15 months and 7-9 years post surgery. However, as no pre-morbid assessments of the participants were available, the direction of causality is less clear. While several studies have found that being physically active is associated with less pain [16, 20, 21, 40] , our results suggest the need for a more complex understanding of the influence of exercise. At 15 months, high-intensity activities (i.e., moderate and strenuous exercise) and performing a job with physical requirements were associated with a lower frequency of pain. At 7-9 years post surgery, this was no longer the case, with weight training measured at 15 months now being associated with an increased risk of pain over time. This information may be relevant when counseling patients regarding health behaviors, as it suggests moderation in advising patients unequivocally to exercise and indicates that some types of exercise may be more relevant than others at different time points after treatment. The role of comorbidity also appeared to change over time. While comorbidity was associated with an increased risk of pain 15 months after surgery, comorbidity was also a predictor of less frequent pain from 15 months to 7-9 years post surgery. One could hypothesize that although pain in cancer patients in general seems to be undertreated [41, 42] , patients with comorbidities may have more contacts with the healthcare system over time, possibly increasing the likelihood that their pain is identified and targeted in treatment.
With respect to possible limitations, we did not include a validated pain questionnaire, e.g., The McGill Pain Questionnaire [43] . However, the pain prevalence reported in the present study is comparable to the prevalence found in a similar large, nationwide cohort study [12] . Although the two studies used different methods to operationalized pain, the comparable prevalence rates tentatively suggest that pain frequency is a reliable and relevant measure of pain. It should also be noted that we have previously found some indications of response bias in our cohort [26] , with responders tending to be younger, more wealthy, and more well-educated than the cohort as a whole, which may slightly overestimate the reported pain prevalence, as younger age has consistently been shown to predict pain [1, 4, 6, 9, 12] . While a common issue in questionnaire-based studies, this may limit the generalizability of the results. In addition, being a longitudinal study with 7-9 years followup, the treatment regimens have been revised since the time of data collection (e.g., implementation of Trastuzumab and taxanes). Finally, despite a prospective study, no premorbid or pre-surgical information on health behaviors and pain were available, thereby limiting conclusions with respect to causality.
Despite these limitations, major strengths of our study are its longitudinal design, that it is based on a large nationwide cohort, the high response rates at follow-up, and the availability of comprehensive pre-cancer socio-demographic data as well as disease-and treatment-related information, allowing for estimations of a wide range of possible sociodemographic, clinical, and health-related risk factors.
Conclusion
Taken together, our results showed that a large proportion of women was found to experience persistent pain after breast cancer treatment, with approximately one in five women reporting high pain frequency even after 7-9 years post surgery. Our results have several clinical implications. First, younger women with low SES, poorer physical function, and women who receive ALND and AI treatment appear to be at higher risk for developing persistent pain. Second, caution should be used regarding excessive weight training. Our results underline the importance of offering interventions for pain soon after patients present pain symptoms, as it appears to become a long-term problem for a substantial number of women.
